BFA Logo Transparent (002).png
RPD ACQUISITION REVIEW: BFA Law Alerts Rapid7, Inc. (Nasdaq:RPD) Shareholders to Contact Us about Investigation into the Company’s Acquisition Price
July 03, 2024 06:18 ET | Bleichmar Fonti & Auld
Shareholders of Rapid7 are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
BFA Logo Transparent (002).png
RPD INVESTIGATION NOTIFICATION: BFA Law Notifies Rapid7, Inc. (Nasdaq:RPD) Investors that it is Investigating the Potential Acquisition, and Urges Shareholders to Contact Us
July 01, 2024 08:11 ET | Bleichmar Fonti & Auld
Shareholders of Rapid7 are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
BFA Logo Transparent (002).png
RPD INVESTIGATION NOTICE: BFA Law Alerts Rapid7, Inc. (Nasdaq:RPD) Investors that it is Investigating the Potential Acquisition, and Urges Shareholders to Contact the Firm
June 29, 2024 06:40 ET | Bleichmar Fonti & Auld
Shareholders of Rapid7 are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
BFA Logo Transparent (002).png
RAPID7 ALERT: BFA Law is Investigating a Potential Transaction between Rapid7, Inc. (Nasdaq:RPD) and Cannae Holdings, Shareholders are Encouraged to Contact the Firm
June 27, 2024 16:45 ET | Bleichmar Fonti & Auld
Shareholders of Rapid7 are encouraged to contact BFA Law about its investigation into potential claims for breach of fiduciary duty against Rapid7, Inc.
Picture1.jpg
Letter to Oncotelic Shareholders on the Recently Completed Joint Venture Transaction with Dragon Overseas Capital Limited
April 07, 2022 10:00 ET | Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), issued the following shareholder letter today. Dear Fellow...